Cellanome

Cellanome R3200 automated cell analysis instrument. Complete platform with flow cells, assays, and cloud analysis for single-cell and ensemble research.

Camilla Valente (UCSF) uses Cellanome’s R3200 platform to identify genes in dendritic cells that enhance T cell priming within immunosuppressive tumor environments.

The R3200 Platform and CellCage technology support high-resolution multimodal analysis of enteric neuroimmune interactions in IBD at single-cell resolution.

The R3200 Platform and CellCage technology converge key hallmarks of senescence to identify specific senescent cell subsets at single-cell resolution.

Integrated morphology-transcriptomics analysis identifies functional cell states in macrophage polarization and tumor-induced reprogramming at single-cell resolution.

Advanced single cell analysis platform uniting live-cell imaging with transcriptomics to capture cellular behavior. Track cellular dynamics over time with CellCage technology for breakthrough biological insights.

GenEng News explores how CellCage enclosure technology connects live-cell behavior to transcriptomic data. The method enables researchers to analyze functional cellular responses alongside gene expression profiles in real time. This approach could advance understanding of dynamic biological processes at the molecular level.

Oct 2026GEN - Genetic Engineering and Biotechnology NewsNews article

Psomagen integrates Cellanome’s CellCage™ technology into its R3200 platform to improve single-cell analysis. The upgrade supports research in immuno-oncology, oncology, and neurobiology by enabling more precise cellular studies. This advancement builds on Psomagen’s focus on high-resolution single-cell solutions for biomedical applications.

Mar 2026psomagen.comNews article

Cellanome demonstrates a live-cell analysis platform combining imaging and sequencing technologies at the AGBT conference. The Bay Area company, led by sequencing experts with Illumina experience, highlights its integrated approach for real-time cellular studies.

Mar 2026genomeweb.comNews article

Cellanome co-founder and executive board member Mostafa Ronaghi discusses live-cell imaging and interaction analysis at scale. A molecular biologist and technology developer, he previously invented pyrosequencing methods for DNA sequencing and served as CTO at Illumina. The conversation explores advancements in observing cellular behavior in real time.

Jan 2025Timmerman ReportNews article